Accellion Provides Update to FTA Security Incident Following Mandiant’s Preliminary Findings

Mandiant Identifies Criminal Threat Actor and Mode of Attacks PALO ALTO, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) — Accellion, Inc., provider of the industry’s first enterprise content firewall, today issued a statement regarding Mandiant’s preliminary findings with regards to the previously reported cyberattacks on Accellion’s legacy FTA product. Mandiant, a division of FireEye, Inc., has identified UNC2546 as the […]

Global Real Estate Leader JLL Begins Transition to Altus Group’s Cloud-Enabled ARGUS Enterprise

Altus Group’s integrated cloud-based software will enable JLL’s businesses to enhance workflow capabilities with a single source of data TORONTO, Feb. 22, 2021 (GLOBE NEWSWIRE) — Altus Group Limited (ʺAltus Groupʺ) (TSX: AIF), a leading provider of commercial real estate (“CRE”) services, software and data solutions, is pleased to announce that JLL, a global leader in commercial real estate […]

Novavax Completes Enrollment of PREVENT-19, COVID-19 Vaccine Pivotal Phase 3 Trial in the United States and Mexico

PREVENT-19 enrolls 30,000 volunteers across 118 sites in the U.S. and Mexico GAITHERSBURG, Md., Feb. 22, 2021 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the complete enrollment of PREVENT-19, its pivotal Phase 3 study in the United States and Mexico to evaluate the […]

TigerGraph Raises $105 Million to Accelerate Graph Analytics on the Cloud

Record Funding for Graph Database Category, Led by Tiger Global, Signals the Next Wave in Analytics to Fuel Powerful Insights for Artificial Intelligence SINGAPORE, Feb. 22, 2021 (GLOBE NEWSWIRE) — TigerGraph, provider of the leading graph analytics platform, today announced it has raised $105 million in Series C funding, the largest funding round to date […]

NMPA Approves Toripalimab in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma after Failure of at Least Two Lines of Prior Systemic Therapy

— 1st approval of any checkpoint inhibitor in nasopharyngeal carcinoma in the world — 2nd indication approved for Toripalimab in China SHANGHAI, China, Feb. 22, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that the National […]